Company Profile

C Light Technologies Inc (AKA: C. LIGHT TECHNOLOGIES, INC. )
Profile last edited on: 4/7/2018      CAGE: 790C0      UEI: FKBJC9XK16F8

Business Identifier: Optics, Biomedical Imaging Devices, Eye-tracking, Neurodegeneration
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1771 Highland Place Suite 8
Berkeley, CA 94709
Location: Single
Congr. District: 13
County: Alameda

Public Profile

C. Light Technologies, Inc. is a biomedical device start-up company focused on the further development and expansion of the tracking laser scanning ophthalmoscope (TSLO) - a non-invasive, precision eye-tracking technology with single-cell light delivery capabilities. With Eye-tracking a factor used to monitor neurological health in many disorders, C.Light is focused to the use of the firm's technology and method for artifact-free eye-tracking in a system that is low cost, robust, and easy to use. The system is accurate, fast and functional eye-tracking system and can be used in a standard ophthalmic instrument. The C. Light system is capable of tracking the eye at 960Hz, with an accuracy of 0.2arcmin. Management plan to make the TSLO more widely available to researchers/academics while ultimately preparing this product for the clinical domain. The most commonly used current tracking technologies employ the use of video-based eye-tracking methods, many of which have an accuracy of 30 arcminutes, or roughly half a degree, and are very expensive. While sufficient for gaze detection, this level of inaccuracy is unacceptable for minute eye movement tracking, disease progression monitoring, and surgical laser guidance. .

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NIH $2,400,083
Project Title: Retinal eye-tracking as a diagnostic tool for traumatic brain injury and concussion.
2018 1 NIH $225,392
Project Title: Retinal Eye-Tracking for the Prognosis and Monitoring of Multiple Sclerosis

Key People / Management

  Christy K Sheehy -- Founder and CEO

  Zach Helft -- Founder

  Andrew Norton

Company News

There are no news available.